Atlas Trials

Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

Clinical trial NCT00221312 · COMPLETED

Trial details

NCT number
NCT00221312
Sponsor
University of California, San Francisco
Status
COMPLETED
Study type
OBSERVATIONAL
Perimenopausal Bone Loss
Start date
2002-05-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.